{"pmid":32391234,"pmcid":"PMC7205364","title":"A Hemodialysis Patient with Severe COVID-19 Pneumonia.","text":["A Hemodialysis Patient with Severe COVID-19 Pneumonia.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a novel coronavirus that has spread rapidly, resulting in a worldwide pandemic. Even though end-stage renal disease (ESRD) patients are particularly susceptible to COVID-19 infection and can develop severe to critical disease, there are limited studies and case reports about COVID-19 in ESRD patients. We report a case of a 63-year-old gentleman with ESRD on regular hemodialysis. We describe the clinical presentation of this patient, the diagnostic process, the laboratory and imaging investigations, as well as the course of treatment. He positively responded to a 14-day course of Lopinavir-Ritonavir, Ribavirin, Azithromycin, and Hydroxychloroquine.","Cureus","Alalwan, Adel A","Taher, Abdulraqeeb","Alaradi, Ali H","32391234"],"abstract":["Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a novel coronavirus that has spread rapidly, resulting in a worldwide pandemic. Even though end-stage renal disease (ESRD) patients are particularly susceptible to COVID-19 infection and can develop severe to critical disease, there are limited studies and case reports about COVID-19 in ESRD patients. We report a case of a 63-year-old gentleman with ESRD on regular hemodialysis. We describe the clinical presentation of this patient, the diagnostic process, the laboratory and imaging investigations, as well as the course of treatment. He positively responded to a 14-day course of Lopinavir-Ritonavir, Ribavirin, Azithromycin, and Hydroxychloroquine."],"journal":"Cureus","authors":["Alalwan, Adel A","Taher, Abdulraqeeb","Alaradi, Ali H"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391234","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.7759/cureus.7995","keywords":["coronavirus","covid-19","hemodialysis"],"locations":["Ribavirin","Azithromycin","Hydroxychloroquine"],"e_drugs":["Ribavirin","lopinavir-ritonavir drug combination","Azithromycin","Hydroxychloroquine"],"topics":["Case Report"],"weight":1,"_version_":1666528579967516672,"score":9.490897,"similar":[{"pmid":32222713,"pmcid":"PMC7179539","title":"A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.","text":["A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.","Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease with an alarming case fatality rate up to 5%. The risk factors for severe presentations are concentrated in patients with chronic kidney disease, particularly patients with end-stage renal disease (ESRD) who are dialysis dependent. We report the first US case of a 56-year-old nondiabetic male with ESRD secondary to IgA nephropathy undergoing thrice-weekly maintenance hemodialysis for 3 years, who developed COVID-19 infection. He has hypertension controlled with angiotensin receptor blocker losartan 100 mg/day and coronary artery disease status-post stent placement. During the first 5 days of his febrile disease, he presented to an urgent care, 3 emergency rooms, 1 cardiology clinic, and 2 dialysis centers in California and Utah. During this interval, he reported nausea, vomiting, diarrhea, and low-grade fevers but was not suspected of COVID-19 infection until he developed respiratory symptoms and was admitted to the hospital. Imaging studies upon admission were consistent with bilateral interstitial pneumonia. He was placed in droplet-eye precautions while awaiting COVID-19 test results. Within the first 24 h, he deteriorated quickly and developed acute respiratory distress syndrome (ARDS), requiring intubation and increasing respiratory support. Losartan was withheld due to hypotension and septic shock. COVID-19 was reported positive on hospital day 3. He remained in critical condition being treated with hydroxychloroquine and tocilizumab in addition to the standard medical management for septic shock and ARDS. Our case is unique in its atypical initial presentation and highlights the importance of early testing.","Am J Nephrol","Ferrey, Antoney J","Choi, Grace","Hanna, Ramy M","Chang, Yongen","Tantisattamo, Ekamol","Ivaturi, Kaushik","Park, Elisa","Nguyen, Lawrence","Wang, Brian","Tonthat, Sam","Rhee, Connie M","Reddy, Uttam","Lau, Wei Ling","Huang, Susan S","Gohil, Shruti","Amin, Alpesh N","Hsieh, Lanny","Cheng, Timmy T","Lee, Richard A","Kalantar-Zadeh, Kamyar","32222713"],"abstract":["Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease with an alarming case fatality rate up to 5%. The risk factors for severe presentations are concentrated in patients with chronic kidney disease, particularly patients with end-stage renal disease (ESRD) who are dialysis dependent. We report the first US case of a 56-year-old nondiabetic male with ESRD secondary to IgA nephropathy undergoing thrice-weekly maintenance hemodialysis for 3 years, who developed COVID-19 infection. He has hypertension controlled with angiotensin receptor blocker losartan 100 mg/day and coronary artery disease status-post stent placement. During the first 5 days of his febrile disease, he presented to an urgent care, 3 emergency rooms, 1 cardiology clinic, and 2 dialysis centers in California and Utah. During this interval, he reported nausea, vomiting, diarrhea, and low-grade fevers but was not suspected of COVID-19 infection until he developed respiratory symptoms and was admitted to the hospital. Imaging studies upon admission were consistent with bilateral interstitial pneumonia. He was placed in droplet-eye precautions while awaiting COVID-19 test results. Within the first 24 h, he deteriorated quickly and developed acute respiratory distress syndrome (ARDS), requiring intubation and increasing respiratory support. Losartan was withheld due to hypotension and septic shock. COVID-19 was reported positive on hospital day 3. He remained in critical condition being treated with hydroxychloroquine and tocilizumab in addition to the standard medical management for septic shock and ARDS. Our case is unique in its atypical initial presentation and highlights the importance of early testing."],"journal":"Am J Nephrol","authors":["Ferrey, Antoney J","Choi, Grace","Hanna, Ramy M","Chang, Yongen","Tantisattamo, Ekamol","Ivaturi, Kaushik","Park, Elisa","Nguyen, Lawrence","Wang, Brian","Tonthat, Sam","Rhee, Connie M","Reddy, Uttam","Lau, Wei Ling","Huang, Susan S","Gohil, Shruti","Amin, Alpesh N","Hsieh, Lanny","Cheng, Timmy T","Lee, Richard A","Kalantar-Zadeh, Kamyar"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32222713","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1159/000507417","keywords":["acute respiratory distress syndrome","end-stage renal disease","novel coronavirus disease 19","rennin-angiotensin-aldosterone system blockade","viral sepsis"],"locations":["US","California","Utah","Losartan"],"countries":["United States"],"countries_codes":["USA|United States"],"e_drugs":["Hydroxychloroquine","tocilizumab","Losartan"],"topics":["Case Report"],"weight":1,"_version_":1666138490223460352,"score":270.79697},{"pmid":32433343,"title":"Impact of the COVID-19 Pandemic on the Management of End-Stage Renal Disease Patients.","text":["Impact of the COVID-19 Pandemic on the Management of End-Stage Renal Disease Patients.","A novel infectious disease, Coronavirus disease -2019 (COVID-19), spread globally since Dec. 2019. Without effective treatment and vaccination, the strategies to restrain this disease is only keeping social distance, maintaining personal hygiene, quarantine and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among dialysis patients, the major societies of nephrology around the world have provided their guidelines of screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and difference of these guidelines and addressed the prompt management for ESRD patients to reduce the risk of infection during COVID-19 pandemic.","J Chin Med Assoc","Li, Szu-Yuan","Tang, Yu-Shuo","Chan, Yu-Jiun","Tarng, Der-Cherng","32433343"],"abstract":["A novel infectious disease, Coronavirus disease -2019 (COVID-19), spread globally since Dec. 2019. Without effective treatment and vaccination, the strategies to restrain this disease is only keeping social distance, maintaining personal hygiene, quarantine and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among dialysis patients, the major societies of nephrology around the world have provided their guidelines of screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and difference of these guidelines and addressed the prompt management for ESRD patients to reduce the risk of infection during COVID-19 pandemic."],"journal":"J Chin Med Assoc","authors":["Li, Szu-Yuan","Tang, Yu-Shuo","Chan, Yu-Jiun","Tarng, Der-Cherng"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433343","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/JCMA.0000000000000356","topics":["Prevention"],"weight":1,"_version_":1667342288318103554,"score":221.37811},{"pmid":32292904,"pmcid":"PMC7103984","title":"Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient.","text":["Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient.","Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of COVID-19 pneumonia among in-center hemodialysis patients. The diagnosis, infection control, and treatment of COVID-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to COVID-19 based on our experiences.","Kidney Med","Tang, Bin","Li, Sijia","Xiong, Yuwan","Tian, Ming","Yu, Jianbin","Xu, Lixia","Zhang, Li","Li, Zhuo","Ma, Jianchao","Wen, Feng","Feng, Zhonglin","Liang, Xinling","Shi, Wei","Liu, Shuangxin","32292904"],"abstract":["Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of COVID-19 pneumonia among in-center hemodialysis patients. The diagnosis, infection control, and treatment of COVID-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to COVID-19 based on our experiences."],"journal":"Kidney Med","authors":["Tang, Bin","Li, Sijia","Xiong, Yuwan","Tian, Ming","Yu, Jianbin","Xu, Lixia","Zhang, Li","Li, Zhuo","Ma, Jianchao","Wen, Feng","Feng, Zhonglin","Liang, Xinling","Shi, Wei","Liu, Shuangxin"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292904","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.xkme.2020.03.001","keywords":["coronavirus disease 2019 (covid-19)","epidemic","hemodialysis","lopinavir/ritonavir","severe acute respiratory syndrome coronavirus 2 virus (sars-cov-2)"],"topics":["Case Report"],"weight":1,"_version_":1666138494321295360,"score":169.70766},{"pmid":32240718,"pmcid":"PMC7118604","title":"COVID-19 in Hemodialysis Patients: A Report of 5 Cases.","text":["COVID-19 in Hemodialysis Patients: A Report of 5 Cases.","In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this case report, we describe the clinical and epidemiologic features of COVID-19 infection in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan University, including 5 maintenance hemodialysis patients who contracted COVID-19 infection. Of the 5 patients with COVID-19 infection, one had a definite history of contact with an infected person. The age range of the patients was 47 to 67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients. Computed tomography of the chest showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, or multiple organ dysfunction) or died.","Am J Kidney Dis","Wang, Rui","Liao, Cong","He, Hong","Hu, Chun","Wei, Zimeng","Hong, Zixi","Zhang, Chengjie","Liao, Meiyan","Shui, Hua","32240718"],"abstract":["In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this case report, we describe the clinical and epidemiologic features of COVID-19 infection in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan University, including 5 maintenance hemodialysis patients who contracted COVID-19 infection. Of the 5 patients with COVID-19 infection, one had a definite history of contact with an infected person. The age range of the patients was 47 to 67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients. Computed tomography of the chest showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, or multiple organ dysfunction) or died."],"journal":"Am J Kidney Dis","authors":["Wang, Rui","Liao, Cong","He, Hong","Hu, Chun","Wei, Zimeng","Hong, Zixi","Zhang, Chengjie","Liao, Meiyan","Shui, Hua"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240718","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1053/j.ajkd.2020.03.009","keywords":["covid-19","hemodialysis","sars-cov-2","case report","chest radiograph","coronavirus","diarrhea","end-stage renal disease (esrd)","symptoms"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138490259111936,"score":157.05307},{"pmid":32340018,"title":"Coronavirus Disease 2019 in a Hemodialysis Patient.","text":["Coronavirus Disease 2019 in a Hemodialysis Patient.","There has been a global outbreak of the coronavirus disease 2019 (COVID-19) since December 2019. Here, we describe the case of a 49-year-old male undergoing maintenance hemodialysis (HD) who got infected with COVID-19 and our experience in performing HD for him. The patient's symptoms and lung imaging changes were atypical. However, his lymphocyte range decreased upon admission and the polymerase chain reaction of the pharyngeal swab for the -COVID-19 nucleic acid was positive. The patient developed respiratory failure and required mechanical ventilation 8 days after admission. In the end, he died from multiple organ dysfunction syndrome. The difficulties in diagnosis, infection control, and treatment of COVID-19 in maintenance HD patients are discussed in this report.","Blood Purif","Yuan, Hai","Guo, E","Gao, Zhao","Hu, Fengqi","Lu, Li","32340018"],"abstract":["There has been a global outbreak of the coronavirus disease 2019 (COVID-19) since December 2019. Here, we describe the case of a 49-year-old male undergoing maintenance hemodialysis (HD) who got infected with COVID-19 and our experience in performing HD for him. The patient's symptoms and lung imaging changes were atypical. However, his lymphocyte range decreased upon admission and the polymerase chain reaction of the pharyngeal swab for the -COVID-19 nucleic acid was positive. The patient developed respiratory failure and required mechanical ventilation 8 days after admission. In the end, he died from multiple organ dysfunction syndrome. The difficulties in diagnosis, infection control, and treatment of COVID-19 in maintenance HD patients are discussed in this report."],"journal":"Blood Purif","authors":["Yuan, Hai","Guo, E","Gao, Zhao","Hu, Fengqi","Lu, Li"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32340018","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1159/000507877","keywords":["coronavirus disease 19","end-stage renal disease","hemodialysis","severe acute respiratory syndrome-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138494155620353,"score":153.71478}]}